Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb Statistics
Share Statistics
Bristol-Myers Squibb has 2.04B shares outstanding. The number of shares has increased by 0.38% in one year.
| Shares Outstanding | 2.04B |
| Shares Change (YoY) | 0.38% |
| Shares Change (QoQ) | 0.32% |
| Owned by Institutions (%) | 78.42% |
| Shares Floating | 2.03B |
| Failed to Deliver (FTD) Shares | 10.2K |
| FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 30.03M, so 1.48% of the outstanding shares have been sold short.
| Short Interest | 30.03M |
| Short % of Shares Out | 1.48% |
| Short % of Float | 1.48% |
| Short Ratio (days to cover) | 1.94 |
Valuation Ratios
The PE ratio is -12.81 and the forward PE ratio is 8.2. Bristol-Myers Squibb's PEG ratio is 0.06.
| PE Ratio | -12.81 |
| Forward PE | 8.2 |
| PS Ratio | 2.37 |
| Forward PS | 2.7 |
| PB Ratio | 7.02 |
| P/FCF Ratio | 8.22 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Bristol-Myers Squibb.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 3.13.
| Current Ratio | 1.25 |
| Quick Ratio | 1.15 |
| Debt / Equity | 3.13 |
| Debt / EBITDA | 16.16 |
| Debt / FCF | 3.67 |
| Interest Coverage | 3.02 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1.42M |
| Profits Per Employee | $-262.4K |
| Employee Count | 34,100 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 5.46 |
Taxes
| Income Tax | 554M |
| Effective Tax Rate | -6.61% |
Stock Price Statistics
The stock price has increased by 13.55% in the last 52 weeks. The beta is 0.41, so Bristol-Myers Squibb's price volatility has been higher than the market average.
| Beta | 0.41 |
| 52-Week Price Change | 13.55% |
| 50-Day Moving Average | 56.21 |
| 200-Day Moving Average | 53.99 |
| Relative Strength Index (RSI) | 39.9 |
| Average Volume (20 Days) | 13.78M |
Income Statement
In the last 12 months, Bristol-Myers Squibb had revenue of 48.3B and earned -8.95B in profits. Earnings per share was -4.41.
| Revenue | 48.3B |
| Gross Profit | 34.33B |
| Operating Income | 5.89B |
| Net Income | -8.95B |
| EBITDA | 3.17B |
| EBIT | -6.43B |
| Earnings Per Share (EPS) | -4.41 |
Balance Sheet
The company has 10.35B in cash and 51.2B in debt, giving a net cash position of -40.85B.
| Cash & Cash Equivalents | 10.35B |
| Total Debt | 51.2B |
| Net Cash | -40.85B |
| Retained Earnings | 14.91B |
| Total Assets | 92.43B |
| Working Capital | 6.71B |
Cash Flow
In the last 12 months, operating cash flow was 15.19B and capital expenditures -1.25B, giving a free cash flow of 13.94B.
| Operating Cash Flow | 15.19B |
| Capital Expenditures | -1.25B |
| Free Cash Flow | 13.94B |
| FCF Per Share | 6.88 |
Margins
Gross margin is 71.08%, with operating and profit margins of 12.19% and -18.53%.
| Gross Margin | 71.08% |
| Operating Margin | 12.19% |
| Pretax Margin | -17.35% |
| Profit Margin | -18.53% |
| EBITDA Margin | 6.56% |
| EBIT Margin | 12.19% |
| FCF Margin | 28.87% |
Dividends & Yields
BMY pays an annual dividend of $3.04, which amounts to a dividend yield of 4.41%.
| Dividend Per Share | $3.04 |
| Dividend Yield | 4.41% |
| Dividend Growth (YoY) | 3.33% |
| Payout Ratio | 113.43% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BMY is $61, which is 21.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $61 |
| Price Target Difference | 21.5% |
| Analyst Consensus | Hold |
| Analyst Count | 16 |
Stock Splits
The last stock split was on Aug 7, 2001. It was a forward split with a ratio of 1000000:951777.
| Last Split Date | Aug 7, 2001 |
| Split Type | forward |
| Split Ratio | 1000000:951777 |
Scores
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 8 |